Description
PRIMO 100 – Metenolone Enanthate (Primobolan) 100mg/ml
PRIMO 100 delivers 100mg/ml of Metenolone Enanthate, one of the most refined anabolic agents available. It is prized for its ability to promote high-quality, lean muscle gains with virtually no estrogenic activity, making it ideal for athletes focused on muscle definition, performance, and long-term body composition enhancement.
Metenolone Enanthate is a DHT-derived compound known for its anabolic properties and minimal androgenic side effects. It enhances nitrogen retention, supports protein synthesis, and helps maintain muscle mass during caloric restriction. Its long-acting ester ensures stable levels with fewer injections per week.
Application:
PRIMO 100 is commonly used during cutting phases or as part of a recomposition stack. It synergizes well with low-dose testosterone or agents like Masteron and Trenbolone for physique refinement without excessive bulk or bloating.
Important Note:
While mild and well-tolerated, PRIMO 100 still suppresses natural testosterone levels with extended use. Post-cycle therapy is advised.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.